SUDARSHANBSESUDARSHAN PHARMA IND LTD· Chemicals & PetrochemicalsHighNeutral
Announced Thu, 29 Oct, 2026 · 22:26 IST

Q2 revenue falls 3%, profit rises 93%; Palghar unit to be shut

Revenue DeclinePat Growth 25pctEbitda Margin CompressionExceptional ItemNegative Operating CashflowResults View source PDFExplain this filing

SUDARSHAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.8%Reaction day
₹37.80
prior close
₹39.04
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending
Specialty Chemicals peers, median of 97sector-2.0%+1.2% vs sector

On the reaction day the stock moved 1.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-4.7
10m
-8.1
15m
-10.5
30m
-7.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.8pendingpending-2.0+1.2
Next day
—————
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 97Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Group Q2 revenue fell 3.2% to Rs 168.87 crore, while profit attributable to shareholders rose 93% to Rs 8.09 crore. First-half revenue fell 19.7% to Rs 314.13 crore, but profit rose 70% to Rs 13.94 crore. Cash from operations was negative Rs 52.71 crore, and auditors raised no material concerns. Standalone results include a Rs 4 crore exceptional charge. The loss-making Palghar unit is being shut.

Likely market impact

Profit rose, but falling sales, margin compression and cash burn are concerns. Palghar closure may cut losses, while funding and dilution add risk.